Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus

Journal of Autoimmunity

Volumn 27, Issue 2, 2006, Pages 119-124

  Wu, Ju Fang ^a,b   Yang, Yao Hsu ^a   Wang, Li Chieh ^a   Lee, Jyh Hong ^a   Shen, Ein Yiao ^b   Chiang, Bor Luen ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anti double stranded DNA antibodies; Antinucleosome antibodies; Systemic lupus erythematosus

Indexed keywords

DOUBLE STRANDED DNA; NUCLEOSOME ANTIBODY;

ADOLESCENT; ADULT; ANAPHYLACTOID PURPURA; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NUCLEOSOMES;

EID: 33749509704     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.07.001     Document Type: Article

References (37)

1. Baqi N., Moazami S., Singh A., Ahmad H., Balachandra S., and Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7 6 (1996) 924-929
2. Riemekasten G., and Hahn B.H. Key autoantigens in SLE. Rheumatology 44 8 (2005) 975-982
3. Sherer Y., Gorstein A., Fritzler M.J., and Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34 2 (2004) 501-537
4. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., and Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76 (2000) 227-324
5. Munoz L.E., Gaipl U.S., Franz S., Sheriff A., Voll R.E., Kalden J.R., et al. SLE - a disease of clearance deficiency?. Rheumatology 44 9 (2005) 1101-1107
6. Sturfelt G., and Truedsson L. Complement and its breakdown products in SLE. Rheumatology 44 10 (2005) 1227-1232
7. Andreassen K., Bredholt G., Moens U., Bendiksen S., Kauric G., and Rekvig O.P. T-cell lines specific for polyomavirus T-antigen recognize T-antigen complexed with nucleosomes: a molecular basis for anti-DNA antibody production. Eur J Immunol 29 9 (1999) 2715-2728
8. Amoura Z., Chabre H., Koutouzov S., Lotton C., Cabrespines A., Bach J.F., et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 37 11 (1994) 1684-1688
9. Burlingame R.W., Boey M.L., Starkebaum G., and Rubin R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94 1 (1994) 184-192
10. Chabre H., Amoura Z., Piette J.C., Godeau P., Bach J.F., and Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 38 10 (1995) 1485-1491
11. Burlingame R.W., Rubin R.L., Balderas R.S., and Theofilopoulos A.N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91 4 (1993) 1687-1696
12. Bruns A., Blass S., Hausdorf G., Burmester G.R., and Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 43 10 (2000) 2307-2315
13. Mohan C., Adams S., Stanik V., and Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177 5 (1993) 1367-1381
14. Suen J.L., Chuang Y.H., Tsai B.Y., Yau P.M., and Chiang B.L. Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells. Arthritis Rheum 50 10 (2004) 3250-3259
15. Simon J.A., Cabiedes J., Ortiz E., Alcocer-Varela J., and Sanchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 43 2 (2004) 220-224
16. Benucci M., Gobbi F.L., Del Rosso A., Cesaretti S., Niccoli L., and Cantini F. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 32 1 (2003) 42-45
17. Ghirardello A., Doria A., Zampieri S., Tarricone E., Tozzoli R., Villalta D., et al. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmun 22 3 (2004) 235-240
18. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
19. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35 6 (1992) 630-640
20. Petty R.E., Southwood T.R., Baum J., Bhettay E., Glass D.N., Manners P., et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25 (1998) 1991-1994
21. Mills J.A., Michel B.A., Bloch D.A., Calabrese L.H., Hunder G.G., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein Purpura. Arthritis Rheum 33 (1990) 1114-1121
22. Sallai K., Nagy E., Derfalvy B., Muzes G., and Gergely P. Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus. Clin Diagn Lab Immunol 12 1 (2005) 56-59
23. Amoura Z., Piette J.C., Chabre H., Cacoub P., Papo T., Wechsler B., et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum 40 12 (1997) 2217-2225
24. Amoura Z., Koutouzov S., Chabre H., Cacoub P., Amoura I., Musset L., et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 43 1 (2000) 76-84
25. Wallace D.J., Lin H.C., Shen G.Q., and Peter J.B. Antibodies to histone (H2A-H2B)-DNA complexes in the absence of antibodies to double-stranded DNA or to (H2A-H2B) complexes are more sensitive and specific for scleroderma-related disorders than for lupus. Arthritis Rheum 37 12 (1994) 1795-1797
26. Hmida Y., Schmit P., Gilson G., and Humbel R.L. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al. Arthritis Rheum 46 1 (2002) 280-282
27. Villalta D., Tozzoli R., Bizzaro N., Tonutti E., Ghirardello A., and Doria A. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays. Ann N Y Acad Sci 1050 (2005) 176-184
28. Min D.J., Kim S.J., Park S.H., Seo Y.I., Kang H.J., Kim W.U., et al. Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol 20 1 (2002) 13-18
29. Ravirajan C.T., Rowse L., MacGowan J.R., and Isenberg D.A. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology 40 12 (2001) 1405-1412
30. Haddouk S., Ben Ayed M., Baklouti S., Hachicha J., Bahloul Z., and Masmoudi H. Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients. Clin Rheumatol 24 3 (2005) 219-222
31. Berden J.H., Licht R., van Bruggen M.C., and Tax W.J. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr Opin Nephrol Hypertens 8 3 (1999) 299-306
32. Amoura Z., Piette J.C., Bach J.F., and Koutouzov S. The key role of nucleosomes in lupus. Arthritis Rheum 42 5 (1999) 833-843
33. Amoura Z., Koutouzov S., and Piette J.C. The role of nucleosomes in lupus. Curr Opin Rheumatol 12 5 (2000) 369-373
34. van Bruggen M.C., Kramers C., Walgreen B., Elema J.D., Kallenberg C.G., van den Born J., et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 12 1 (1997) 57-66
35. Gonzalez C., Garcia-Berrocal B., Herraez O., Navajo J.A., and Gonzalez-Buitrago J.M. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus. Clin Chem Lab Med 42 3 (2004) 266-272
36. Rahman A., and Hiepe F. Anti-DNA antibodies - overview of assays and clinical correlations. Lupus 11 12 (2002) 770-773
37. Suenaga R., Mitamura K., and Abdou N.I. Isolation of anti-nucleosome antibodies from the plasma of lupus nephritis patients. Clin Rheumatol 17 3 (1998) 189-194